Journal Mobile Options
Table of Contents
Vol. 18, No. 4, 1999
Issue release date: July–August 1999

Association of Cigarette Smoking with Amyotrophic Lateral Sclerosis

Kamel F. · Umbach D.M. · Munsat T.L. · Shefner J.M. · Sandler D.P.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

We explored the relationship between amyotrophic lateral sclerosis (ALS) and cigarette smoking in a case-control study conducted in New England from 1993 to 1996. Recently diagnosed ALS cases (n = 109) were recruited from two major referral centers. Population controls (n = 256) were identified by random telephone screening. Data were analyzed by logistic regression. After adjusting for age, sex, region and education, ever having smoked cigarettes was associated with an increase in risk for ALS (odds ratio 1.7; 95% confidence interval 1.0–2.8). Average cigarettes smoked per day, years smoked and pack-years were all greater in cases than controls, but dose-response trends were not observed. Similar numbers of cases and controls had ever used alcohol, and only a small, nonsignificant association of drinks per month with ALS was observed. The association of cigarette smoking with ALS was not affected by adjusting for alcohol use. In contrast, the weak relationship of ALS with alcohol use was apparently due to confounding by smoking.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Nelson LM: Epidemiology of ALS. Clin Neurosci 1995–1996;3:327–331.
  2. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, Oregan JP, Deng HX, Rahmani Z, Krizus A, Mckennayasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Vandenbergh R, Hung WY, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance MA, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59–62.
  3. Olanow CW, Arendash GW: Metals and free radicals in neurodegeneration. Curr Opin Neurol 1994;7:548–558.
  4. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ: Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198–1203.
  5. Chancellor AM, Slattery JM, Fraser H, Warlow CP: Risk factors for motor neuron disease – A case-control study based on patients from the Scottish motor neuron disease register. J Neurol Neurosurg Psychiatry 1993;56:1200–1206.
  6. Granieri E, Carreras M, Tola R: Motor neuron disease in the province of Ferrara, Italy, in 1964–1982. Neurology 1988;38:1604–1608.
  7. Kondo K, Tsubaki T: Case-control studies of motor neuron disease: Association with mechanical injuries. Arch Neurol 1981;38:220–226.
  8. Li TM, Alberman E, Swash M: Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1990;53:1043–1045.
  9. Pierce-Ruhland R, Patten BM: Repeat study of antecedent events in motor neuron disease. Ann Clin Res 1981;13:102–107.
  10. Provinciali L, Giovagnoli AR: Antecedent events in amyotrophic lateral sclerosis: Do they influence clinical onset and progression? Neuroepidemiology 1990;9:255–262.
  11. Savettieri G, Salemi G, Arcara A, Cassata M, Castiglione MG, Fierro B: A case-control study of amyotrophic lateral sclerosis. Neuroepidemiology 1991;10:242–245.
  12. Nelson LM, Longstreth WT Jr, McGuire V, Matkin C: Cigarette smoking and risk of amyotrophic lateral sclerosis: A population-based case-control study (abstract). Neuroepidemiology 1998;17:210.
  13. Morens DM, Grandinetti A, Reed D, White LR, Ross GW: Cigarette smoking and protection from Parkinson’s disease: False association or etiologic clue? Neurology 1995;45:1041–1051.
  14. Waksberg J: Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40–46.
  15. Battaglia M, Camburn D, Massey J, Tompkins L: Calling local telephone company business offices to determine the residential status of a wide class of unresolved telephone numbers in a random-digit dialing sample. Am Assoc Public Opin Res Proc 1995;975–980.
  16. Rajput AH, Offord KP, Beard CM, Kurland LT: A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson’s disease. Neurology 1987;37:226–232.

    External Resources

  17. Mayeux R, Tang MX, Marder K, Cote LJ, Stern Y: Smoking and Parkinsons Disease. Mov Disord 1994;9:207–212.
  18. Bharucha NE, Stokes L, Schoenberg BS, Ward C, Ince S, Nutt JG, Eldridge R, Calne DB, Mantel N, Duvoisin R: A case-control study of twin pairs discordant for Parkinson’s disease: A search for environmental risk factors. Neurology 1986;36:284–288.

    External Resources

  19. Grandinetti A, Morens DM, Reed D, MacEachern D: Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson’s disease. Am J Epidemiol 1994;139:1129–1138.
  20. Nisell M, Nomikos GG, Svensson TH: Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 1995;76:157–162.
  21. Baron JA: Cigarette smoking and Parkinson’s disease. Neurology 1986;36:1490–1496.

    External Resources

  22. Graves AB, Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A: Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S48–S57.
  23. Bowling AC, Beal MF: Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 1995;56:1151–1171.

    External Resources

  24. Weeks MF, Kulka RA, Lessler JT, Whitemore RW: Personal versus telephone surveys for collecting household health data at the local level. Am J Publ Health 1983;73:1389–1394.

    External Resources

  25. Eisen A, Calne D: Amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease: Phylogenetic disorders of the human neocortex sharing many characteristics. Can J Neurol Sci 1992;19:117–123.
  26. Deapen DM, Hendeson BE: A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol 1986;123:790–799.
  27. Gunnarsson LG, Bodin L, Soderfeldt B, Axelson O: A case-control study of motor neurone disease – Its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med 1992;49:791–798.
  28. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP: Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson’s disease: Evidence of shared genetic susceptibility. Neurology 1994;44:1872–1877.
  29. Felmus MT, Patten BM, Swanke L: Antecedent events in amyotrophic lateral sclerosis. Neurology 1976;26:167–172.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50